Clarivate (CLVT) Stock Forecast, Price Target & Predictions
CLVT Stock Forecast
Clarivate (CLVT) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $3.30, with a high of $3.60 and a low of $3.00. This represents a 14.19% increase from the last price of $2.89.
CLVT Stock Rating
Clarivate stock's rating consensus is Hold, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (25.00%), 11 Hold (55.00%), 4 Sell (20.00%), and 0 Strong Sell (0.00%).
Hold
CLVT Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Clarivate | 14.19% |
| Sector | Technology Stocks | 25.72% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 3 |
| Avg Price Target | $3.60 | $3.60 | $3.60 |
| Last Closing Price | $2.89 | $2.89 | $2.89 |
| Upside/Downside | 24.57% | 24.57% | 24.57% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Jan, 26 | 1 | 2 | 5 | 1 | 1 | 10 |
| Dec, 25 | 1 | 2 | 6 | - | 1 | 10 |
| Nov, 25 | 1 | 3 | 6 | - | 1 | 11 |
| Oct, 25 | 1 | 3 | 6 | - | 1 | 11 |
| Sep, 25 | 1 | 3 | 5 | - | 1 | 10 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 08, 2026 | Goldman Sachs | $3.60 | $3.36 | 7.14% | 24.57% | |
| Dec 17, 2025 | Morgan Stanley | $3.00 | $3.57 | -15.97% | 3.81% | |
| Oct 30, 2025 | Goldman Sachs | $4.20 | $3.36 | 25.00% | 45.33% | |
| Jun 13, 2023 | Owen Lau | Oppenheimer | $11.00 | $8.99 | 22.36% | 280.62% |
| Feb 06, 2023 | Morgan Stanley | $12.00 | $11.19 | 7.24% | 315.22% | |
| Apr 19, 2022 | Goldman Sachs | $20.00 | $17.07 | 17.16% | 592.04% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jan 08, 2026 | Goldman Sachs | Neutral | downgrade | |
| Dec 17, 2025 | Morgan Stanley | Equal-Weight | Underweight | downgrade |
| Sep 03, 2025 | Wolfe Research | Peer Perform | initialise | |
| Sep 08, 2023 | Barclays | Underweight | downgrade | |
| Jun 13, 2023 | Oppenheimer | Outperform | initialise | |
| Feb 06, 2023 | Morgan Stanley | Equal-Weight | downgrade |
Financial Forecast
EPS Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|
| Reported | $-6.28 | $-5.86 | $-1.47 | $-0.96 | - | - | - |
| Avg Forecast | $0.70 | $0.80 | $0.80 | $0.73 | $0.73 | $0.79 | $0.88 |
| High Forecast | $0.71 | $0.84 | $0.83 | $0.75 | $0.78 | $5.55 | $0.94 |
| Low Forecast | $0.69 | $0.77 | $0.79 | $0.71 | $0.66 | $-4.76 | $0.81 |
| Surprise % | -997.14% | -832.50% | -283.75% | -231.51% | - | - | - |
Revenue Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|
| Reported | $2.66B | $2.66B | $2.63B | $2.56B | - | - | - |
| Avg Forecast | $1.88B | $2.64B | $2.63B | $2.56B | $2.55B | $2.62B | $2.68B |
| High Forecast | $1.90B | $2.72B | $2.64B | $2.57B | $2.59B | $2.63B | $2.69B |
| Low Forecast | $1.86B | $2.55B | $2.62B | $2.55B | $2.47B | $2.62B | $2.68B |
| Surprise % | 41.54% | 0.82% | -0.08% | -0.12% | - | - | - |
Net Income Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|
| Reported | $-3.96B | $-3.96B | $-911.20M | $-668.00M | - | - | - |
| Avg Forecast | $468.64M | $115.71M | $-986.60M | $490.11M | $485.01M | $6.78M | $587.65M |
| High Forecast | $474.12M | $138.85M | $-789.28M | $503.73M | $525.43M | $3.73B | $629.63M |
| Low Forecast | $463.50M | $92.57M | $-1.18B | $476.50M | $444.59M | $-3.19B | $545.67M |
| Surprise % | -945.05% | -3522.52% | -7.64% | -236.29% | - | - | - |